rs674302
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000611156.4(ABO):c.28+3913T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.616 in 151,632 control chromosomes in the GnomAD database, including 29,108 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.62 ( 29108 hom., cov: 30)
Consequence
ABO
ENST00000611156.4 intron
ENST00000611156.4 intron
Scores
1
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.45
Publications
31 publications found
Genes affected
ABO (HGNC:79): (ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase) This gene encodes proteins related to the first discovered blood group system, ABO. Variation in the ABO gene (chromosome 9q34.2) is the basis of the ABO blood group, thus the presence of an allele determines the blood group in an individual. The 'O' blood group is caused by a deletion of guanine-258 near the N-terminus of the protein which results in a frameshift and translation of an almost entirely different protein. Individuals with the A, B, and AB alleles express glycosyltransferase activities that convert the H antigen into the A or B antigen. Other minor alleles have been found for this gene. [provided by RefSeq, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.705 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ABO | NR_198898.1 | n.40+3913T>A | intron_variant | Intron 1 of 6 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ABO | ENST00000611156.4 | c.28+3913T>A | intron_variant | Intron 1 of 7 | 5 | ENSP00000483265.1 |
Frequencies
GnomAD3 genomes AF: 0.617 AC: 93415AN: 151518Hom.: 29087 Cov.: 30 show subpopulations
GnomAD3 genomes
AF:
AC:
93415
AN:
151518
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.616 AC: 93474AN: 151632Hom.: 29108 Cov.: 30 AF XY: 0.615 AC XY: 45543AN XY: 74086 show subpopulations
GnomAD4 genome
AF:
AC:
93474
AN:
151632
Hom.:
Cov.:
30
AF XY:
AC XY:
45543
AN XY:
74086
show subpopulations
African (AFR)
AF:
AC:
22659
AN:
41310
American (AMR)
AF:
AC:
10923
AN:
15256
Ashkenazi Jewish (ASJ)
AF:
AC:
1990
AN:
3462
East Asian (EAS)
AF:
AC:
3169
AN:
5148
South Asian (SAS)
AF:
AC:
2707
AN:
4798
European-Finnish (FIN)
AF:
AC:
5660
AN:
10474
Middle Eastern (MID)
AF:
AC:
196
AN:
294
European-Non Finnish (NFE)
AF:
AC:
44521
AN:
67880
Other (OTH)
AF:
AC:
1330
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.531
Heterozygous variant carriers
0
1765
3530
5294
7059
8824
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
774
1548
2322
3096
3870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.